COMPANY

Illexcor Therapeutics

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $13M (Form D filed May 8, 2026). SEC Form D 0002132799-26-000001 (May 8, 2026)
Evidence (1 event)
- May 8, 2026 · SEC Form D 0002132799-26-000001
  Name of Issuer: Illexcor Therapeutics, Inc.; CIK: 2132799; Address: Henrico, VA; Submission type: D; Filing date: 2026-05-08; Industry Group: Biotechnology; Date of First Sale: 2026-04-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 69000000; Total Amount Sold: 13000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 21, 2025 Grant Government grant — SBIR: $529,259 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Jul 16, 2025 Grant Government grant — SBIR: $798,351 (annual award, as published), announced Jul 16, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

Last 2 years.

Aug 21, 2025 Government grant — SBIR: $529,259 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Jul 16, 2025 Government grant — SBIR: $798,351 (annual award, as published), announced Jul 16, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗